86. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System to Prevent the Onset of Neurologic Deficits in a Murine Model of Mucopolysaccharidosis Type II
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)32895-7
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV